Aug. 19 at 4:57 PM
$BMEA People can sell this and buy another biotech such as MRNA, since it has such a breakthrough discovery. Which I think is what happened this morning.
However the only issue is that, they weren’t FDA approved yet, but it rose 100%+ rise which for such a big company is interesting.
Secondly, if 1 breakthrough drug can do such gains for such a big company. You can somewhat imagine what would happened here, when you have not 1 but 2 possible drugs.
Just from MRNA you can see that good data, can bring in 30-40B in 1 day without FDA approval. Now ofc this is cancer so huge money is self explanatory. But goes to show for almost any biotech.
In my opinion, with BMEA, it’s not even about the price of the stock anymore. It’s not even worth looking at ngl. But once good data hits, with any one of the drugs.
It’ll be funny how the people that sold start flying to get back in.
Compare MRNA going from 30B to 60B for 100% gains. Then BMEA going from under 100m to ?B, do the math yourself.
